Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.

Antimicrobial agents and chemotherapy - 1 Dec 2002

Oliver Antonio, Weigel Linda M, Rasheed J Kamile, McGowan John E, Raney Patti, Tenover Fred C

Abstract excerpt

Cefpodoxime is one of five antimicrobial agents recommended by the National Committee for Clinical Laboratory Standards for screening isolates of Klebsiella spp. and Escherichia coli for extended-spectrum beta-lactamase (ESBL) production. In a prior study, we noted that among 131 E. coli isolates for which the MIC of at least one extended-spectrum cephalosporin (ESC) or aztreonam was > or =2 micro g/ml...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple

Share to Electrophoresis, Gel, Pulsed-Field

Share to Escherichia coli

Share to Microbial Sensitivity Tests

Share to Phenotype

Share to Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 12435684
DOI: 10.1128/AAC.46.12.3829-3836.2002
PMCID: PMC132766

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.PMID 12435684Read ↗

Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.Semantic proximity Read ↗

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)Semantic proximity Read ↗

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates.Semantic proximity Read ↗

Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.Semantic proximity Read ↗

Activity of cefepime and other beta-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae.Semantic proximity Read ↗

A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.Semantic proximity Read ↗

False extended-spectrum β-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porinsSemantic proximity Read ↗

The Prevalence of Fluoroquinolone Resistance Mechanisms in Colonizing Escherichia coli Isolates Recovered from Hospitalized PatientsSemantic proximity Read ↗

beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.Semantic proximity Read ↗

Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.Semantic proximity Read ↗

SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.Semantic proximity Read ↗

Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coliSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.